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842-3 Blunted Erythropoietin Production and Defective Iron 
Supply for Erythropoiesis as Major Causes of Anemia in 
Patients With Chronic Heart Failure
Cristina Opasich, Mario Cazzola, Stefania De Feo, Enzo Bosimini, Rocco La Gioia, 
Oreste Febo, Roberto Ferrari, Gloria Francolini, Remiglio Moratti, Laura Scelsi, Maurizio 
Volterrani, Roberto Tramarin, Luigi Tavazzi, Fondazione Salvatore Maugeri, Pavia, Italy, 
Policlinico San Matteo, Pavia, Italy
BACKGROUND Recent studies have shown that anemia is a common comorbid condi-
tion in patients with chronic heart failure (CHF), suggesting an impact on history and
prognosis.
AIM To investigate the mechanisms of anemia in a series of consecutive anemic CHF
patients and define a rational therapeutic approach.
METHODS A series of 148 consecutive adult CHF pts with Hb <13 g/dL (males) or <12
g/dL (females) was studied. Potential responsible factors for anemia were investigated by
evaluating endogenous erythropoietin (Epo) production, serum cytokines levels (TNF-
alpha and its soluble receptors, IL-6 and IL-1Ra), body iron status, and iron supply for
erythropoiesis.
RESULTS 105 pts (71%) had evidence of severe defective endogenous erythropoietin
production, indicated by an observed/predicted log(serum Epo) ratio <0.8; 85 pts (57%)
had low serum iron (mean value for men 105, for women 45 ng/mL; 61 (41%) had low
transferrin saturation (mean value 22% for men and 23% for women) and 85 (57%) had
increased levels for soluble transferrin receptor. Impaired iron supply to erythropoiesis, as
indicated by low transferrin saturation and/or increased values for soluble transferrin
receptor, was observed in 105 pts (71%). Elevated values for high sensitivity C-reactive
protein (mean value 0.69 for men and 0.61 mg/dL for women) were found in 83 pts
(56%), increased serum creatinine in 44 pts (30%), cytokines activation in 133 pts (90%).
CONCLUSION Our findings demonstrate that the vast majority of anemic CHF pts shows
evidence of blunted endogenous erythropoietin production and/or defective iron supply
for erythropoiesis. Therefore, the assessment of serum erythropoietin and the evaluation
of body iron status represent a rational approach to treatment of the individual patient:
according to those physiopathologic findings in most instances, subcutaneous adminis-
tration of recombinant human erythropoietin combined with iv iron would represent the
optimal therapeutic approach.
11:15 a.m.
842-4 Deranged Steroid Metabolism Independently Predicts 
Anemia in Chronic Heart Failure
Darlington O. Okonko, Martino Crosato, Paul R. Kalra, Mariantonietta Cicoira, Wolfram 
Steinborn, Wolfram Doehner, Phillip A. Poole-Wilson, Andrew J. Coats, Stefan D. Anker, 
Imperial College, National Heart and Lung, London, United Kingdom, Applied Cachexia 
Research, Charité, Virchow-Klinikum, Berlin, Germany
Background: The pathogenesis of anemia in chronic heart failure (CHF) is poorly under-
stood. It may be secondary to abnormalities in CHF. Adrenal metabolism in CHF is char-
acterised by the predominance of catabolic (cortisol) over anabolic (androgen) steroids.
As erythropoiesis is normally stimulated by androgens and can be depressed by chronic
cortisol excess, we hypothesised that the steroid imbalance in CHF may contribute to
anemia.
Methods: We assessed the relationship between plasma hemoglobin and the cortisol/
DHEA ratio (CDR) in 92 male CHF patients. CDR values are log-transformed.
Results: Mean age of patients was 61±11 y, body mass index 26.3±4.5 kg/m2, NYHA
class 2.6±0.7, peak oxygen consumption(VO2) 18.1±6.0 mL/kg/m2, ventilation/carbon
dioxide production slope 38±13, left ventricular ejection fraction 25±11%, urate 473±139
µmol/L, cortisol 410±12 nmol/L, DHEA 13.3±9.1 nmol/L, logCDR 1.57±0.33 (range: 0.89-
2.53), Cockroft-Gault calculated glomerular filtration rate (GFRc) 111±50 mL/min. 13
patients (14%) were anemic (hemoglobin < 12 g/dL, microcytic: 1 [8%], macrocytic: 1
[8%]). Anemic patients were older, with lower peak VO2, lower GFRc, higher urate and
higher logCDR (all p<0.001). In univariate regression analysis, determinants of hemoglo-
bin were logCDR (r=-.41, p<0.0001), GFRc (r=0.36, p=0.0004), body mass index (r=0.32,
p=0.002), age (r=-0.30, p=0.004), serum urate (r=-0.27, p<0.02) and peak VO2 (r=0.26,
p<0.02). Only CDR and GFRc remained independent predictors of hemoglobin on step-
wise regression analysis (1. step: partial correlation for logCDR =-0.43, F=19.6; 2. step:
partial correlation for GFRc =0.28, F=8.3; joint R=0.51). The relationship between CDR
and hemoglobin in patients with impaired exercise capacity (peak VO2<18) was stronger
than in those with preserved exercise capacity (peak VO2>18) (r=0.45, p<0.002 vs
r=0.21, p=0.18, respectively).
Conclusion: Altered steroid metabolism, as measured by the cortisol/DHEA ratio, is a
strong independent predictor of hemoglobin levels in male CHF patients. This relation-
ship strengthens with disease severity, further suggesting an etiological link between
anemia and steroid imbalance in CHF.
11:30 a.m.
842-5 Anemia Is Common in Patients With Heart Failure Seen 
in Specialty and Community Cardiology Clinics: Results 
From the STAMINA:HFP Registry (Study of Anemia in a 
Heart Failure Population)
Lynne E. Wagoner, Javed Butler, Ron Oren, Jalal K. Ghali, Ileana Pina, Alan Miller, J. 
Herbert Patterson, Mick O'Quigley, Carla A. Sueta, Michael James, Shaival Kapadia, 
Christopher M. O'Connor, Todd A. Schwartz, Kirkwood F. Adams, The STAMINA-HFP 
Investigators, University of North Carolina - Chapel Hill, Chapel Hill, NC
Background. Extent of anemia and factors associated with reduced hemoglobin (Hgb) in
randomly selected outpatients (Pts) with heart failure (HF) have not been well described.
Methods. Anemia in HF was evaluated from the STAMINA-HFP Registry, a prospective,
observational study enrolling randomly selected Pts from 12 specialty and 45 community
cardiology clinics. The following characteristics were tested for their association with ane-
mia (Hgb <12 g/dl for females; <13 g/dl for males): age, NYHA class, blood pressure,
pulse, estimated glomerular filtration rate (eGFR), hypertension, diabetes, chronic
obstructive lung disease, current smoking, and angiotensin converting enzyme inhibitor
or beta blocker use. Anemia status was available in 982 (326 specialty; 656 community)
of the 1089 Pts enrolled, who were 41% female, 75% Caucasian with an age (mean
±SD) of 64±14 years.
Results. Anemia was present in 33% and its frequency was similar in specialty and com-
munity sites (32 vs. 34%, p=0.675). Mean Hgb was 13.3±1.8 g/dl (median 13.3 g/dl).
Lower eGFR, higher NYHA class, male gender, lower diastolic blood pressure, higher
systolic blood pressure, and African-American ethnicity were predictors of anemia (all
others p>0.15). Significant predictors of anemia are shown. 
Conclusion. Anemia is common in randomly selected Pts with HF and is associated with 
standard clinical characteristics. This high prevalence supports efforts to investigate the 
potential beneficial effect of correcting anemia in Pts with HF.
11:45 a.m.
842-6 Anemia Is Associated With Reduced Health Status 
Measures in Patients With Heart Failure: Results From 
the STAMINA:HFP (Study of Anemia in a Heart Failure 
Population) Registry
Kirkwood F. Adams, Jr., Ileana Pina, Biljana Pavlovic-Surjancev, Lynne E. Wagoner, 
Stephanie H. Dunlap, Todd A. Schwartz, Wendy A. Gattis, Mandeep R. Mehra, Jalal K. 
Ghali, David Wolinski, William Pitt, John Kim, Javed Butler, Ron M. Oren, The STAMINA-
HFP Investigators, University of North Carolina - Chapel Hill, Chapel Hill, NC
Background. Anemia is associated with adverse outcomes in heart failure (HF). How-
ever, the relationship of hemoglobin (Hgb) to quality of life (QoL) in outpatients with HF is
unknown.
Methods. The association between QoL and Hgb in HF was assessed in the STAMINA-
HFP Registry, a prospective, observational study enrolling randomly selected patients
from HF specialty clinics involved in the UNITE-HF database or from community cardiol-
ogy practice clinics. QoL was prospectively determined by telephone contact at baseline
for the Kansas City Cardiomyopathy Questionnaire (KCCQ) - higher score reflects better
QoL and Minnesota Living with Heart Failure (MLHF) Questionnaire - lower score reflects
better QoL. Anemia was defined as a Hgb <12 g/dl in females and <13 g/dl in males.
Results. Baseline Hgb, gender and QoL data were available in 780 (249 specialty, 531
community) of the 1089 patients enrolled in the registry. The cohort was 42% female,
77% Caucasian, with an age (mean±SD) of 64 ± 14 years. Mean Hgb was 13.2 ± 1.8 g/
dl. Significant relationships between QoL and Hgb, as a continuous variable, remained
after adjusting for age, gender, race, diabetes, NYHA class and LVEF for KCCQ scores
(all p<0.05) and for Physical and Summary MLHF scores (p<0.03) after adjustment for all
these variables except NYHA class. 
Clinical Characteristic Odds Ratio
for anemia
95% CI P
eGFR* per 10ml/min 0.79 0.74 - 0.85 <0.001
NYHA class per unit 1.31 1.06 - 1.61 0.011
Gender (female vs. male) 0.60 0.44 - 0.83 0.002
Ethnicity (African-American yes vs. no) 1.90 1.31 - 2.76 <0.001
DBP per 5mmHg 0.78 0.72 - 0.86 <0.001
SBP per 5mmHg 1.07 1.02 - 1.12 0.006
eGFR=estimated glomerular filtration rate, DBP=diastolic blood pressure, SBP=systolic 
blood pressure, CI = confidence interval.
*estimated using a form of the Modification of Diet in Renal Disease equation 
(incorporates age, gender, race, and serum creatinine)
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Conclusions. These data suggest that anemia is associated with reduced QoL in 
patients with HF. Additional studies will be required to establish if this is a cause and 
effect relationship.
POSTER SESSION
1144 Basic Science Studies in Animal Models 
of Heart Failure
Tuesday, March 09, 2004, Noon-2:00 p.m.
Morial Convention Center, Hall G
Presentation Hour: 1:00 p.m.-2:00 p.m.
1144-103 Chronic Infusion of Bradykinin Preserves Vascular 
Nitric Oxide-Mediated Endothelial Function and Limits 
the Alteration in Left Ventricular Function During 
Pacing-Induced Heart Failure in Conscious Dogs
Jinbo Su, Daniel Tonduangu, Bijan Ghaleh, Philippe Le Corvoisier, Fanny Vincent, 
Thierry Badoual, Lucien Sambin, Alain Berdeaux, Bertrand Crozatier, Luc Hittinger, 
INSERM, Créteil, France, INSERM, Kremlin-Bicêtre, France
It has been shown that bradykinin (BK) is involved in the beneficial effects of angiotensin-
converting enzyme inhibitors on vascular endothelial and left ventricular (LV) functions in
heart failure (HF). However, it is not known whether BK per se exerts a protective action
on vascular and cardiac functions during the development of HF. This study examined the
effects of chronic BK infusion on cardiac and vascular nitric oxide (NO)-mediated endot-
helial functions during pacing-induced HF in conscious dogs. Sixteen beagle dogs were
chronically instrumented to measure cardiac output, LV pressure, LV wall thickness and
left and right atrial and aortic pressures. After baseline recording and examining the
vasodilator responses to intravenous acetylcholine (ACh, 0.3-3 µg/kg) and nitroglycerin
(NTG, 1-10 µg/kg) in the control state, dogs were randomized to receive through left atria
either water (vehicle group) or BK (1 µg/min, which does not change systemic hemody-
namics; BK group) during right ventricular pacing (250 beats/min, 5 weeks). The vasodi-
lator responses to ACh and NTG were again examined after 3 and 5 weeks of pacing.
The expression of endothelial NO synthase (eNOS) in femoral, carotid and renal arteries
was determined by Western blot analysis. After 3 weeks of pacing, the BK group had a
lesser degree of HF than the vehicle group as indicated by less alterations in LV end-
diastolic pressure (+10±3 vs +19±2 mmHg, p<0.05), LV wall thickening (-33±18 vs -
75±9%, p<0.05) and cardiac output (-16±6 vs -32±6%, p<0.05). Total peripheral resis-
tance (TPR) increased in the vehicle group (+18±10%, p<0.05) but remained unchanged
in the BK group (+1±8%). In both groups during HF, TPR response to NTG was not
altered. In contrast, TPR response to ACh was blunted in the vehicle group (p<0.01) but
was unchanged in the BK group. Similar trends were also observed after 5 weeks of pac-
ing. In all examined arterial beds, eNOS protein expression decreased significantly in the
vehicle group but was preserved in the BK group. Thus, in conscious dogs, chronic BK
infusion limits alterations in LV function and preserves vascular endothelial NO-mediated
vasodilation and thereby delays the progression of HF.
1144-104 The Novel Organic Nitroxyl Donor, Isopropylamine/Nitric 
Oxide Exerts Beta-Independent Positive Inotropy/
Lusitropy in Failing Hearts
Tatsuo Katori, Carlo G. Tocchetti, Katrina M. Miranda, Hunter C. Champion, Jon M. 
Fukuto, David A. Wink, David A. Kass, Nazareno Paolocci, The Johns Hopkins 
University, Baltimore, MD, National Institutes of Health, Bethesda, MD
BackGround: The Nitroxyl (HNO/NO-) donor Angeli’s salt (AS) is a potent inotropic/lusi-
tropic agent both in healthy and heart failure dogs. Its action linked in part to activation of
non-adrenergic/non-cholinergic (NANC) fibers to release calcitonin gene-related peptide
(CGRP). However, AS chemistry may involve generation of other NO-related species, i.e.
nitrates. To more specifically assess HNO/NO- signaling, we developed and tested a
novel organic compound isopropylamine/NO (IPA/NO), a near pure (>95%) HNO/NO-
donor.
Methods: Pressure-volume relations were assessed in conscious dogs under basal con-
ditions and after induction of heart failure (HF) by tachypacing.
Results: IPA/NO (5µg/kg/min) increased contractility (end-systolic elastance, Ees,) by
58.0±8.1% (p<0.001) in control and 46.8±10.2% (p<0.01) in HF, and lowered preload and
afterload similarly in healthy and CHF dogs. This contrasted to negative inotropic effects
from equidilative doses of diethylamine/NO (DEA/NO, pure NO donor, 2µg/kg/min), S-
Nitrosoglutathione (GSNO, pure NO doror, 0.625µg/kg/min) or nitroglycerin (NTG, 10µg/
kg/min). Isovolumic relaxation was 6.1±3.8% faster with IPA/NO in control hearts, and
this effect was more pronounced in HF (28.3±6.4%; p<0.05 vs. control hearts). Co-infu-
sion of dobutamine with IPA/NO further augmented contractility by 46.0±16% (p<0.05) in
control and 31.4+/-6.5% (p<0.05) in HF above dobutamine alone, whereas DEA/NO,
GSNO or NTG blunted β-stimulation. IPA/NO inotropic/lusitropic action was unaffected by
β-blockade (timolol, 2mg/kg). IPA/NO increased arterial plasma CGRP (30.3±6.0 to
65.1±2.8 pg/ml; p<0.005) and neurotensin (78.6±7.3 to 170.0±25.3pg/ml; p<0.01),
reflecting NANC stimulation. Responses to IPA/NO were very similar to those previously
reported from AS.
Conclusion: The novel HNO/NO- donor, IPA/NO, has potent inotropic and lusitropic
effects in failing hearts that are synergistic with β-agonist stimulation. Unlike inorganic
AS, this new organic compound has potential for clinical development as an NO-related
species with both vasoactive and cardiotropic effects, for use in the treatment of heart
failure.
1144-127 Effects of Inotropic Stimulation on Left Ventricular 
Torsional Deformation in Tachycardia-Induced Dilated 
Cardiomyopathy
Filiberto Rodriguez, Katherine B. Harrington, Frederick A. Tibayan, Paul Dagum, Frank 
Langer, George T. Daughters, Neil B. Ingels, Jr., D. Craig Miller, Stanford University, 
Stanford, CA, Palo Alto Medical Foundation, Palo Alto, CA
Introduction: Tachycardia-induced cardiomyopathy (TIC) is accompanied by decreased
and delayed systolic left ventricular (LV) torsion and loss of early diastolic recoil, which
may contribute to LV dysfunction by increasing systolic transmural strain gradients and
impairing diastolic filling. To gain more mechanistic understanding of the pathophysiology
of this model of congestive heart failure (CHF), we examined the effects of inotropic stim-
ulation on torsional deformation at baseline and after the development of TIC.
Methods: Seven sheep had radiopaque markers implanted in the LV subepicardium to
measure: 1.) maximal systolic torsion (Φmax); and, 2.) diastolic torsion recoil during the
first 5% of filling (Φ5%) using biplane videofluoroscopy (60 Hz) one week after surgery,
before and during inotropic stimulation with dobutamine. Rapid ventricular pacing was
then implemented for 15±6 days to create TIC, and data were again acquired before and
during dobutamine infusion.
Results: Maximal torsion and recoil rate were restored to near-normal levels in TIC with
dobutamine (Table).
Conclusions: Inotropic stimulation with dobutamine may benefit patients with CHF, in
part, by restoring LV torsion dynamics, which may decrease systolic transmural strain
gradients and augment early-diastolic filling.
QoL
unadjusted 
scores
(mean±SD)
Anemia
(n)
Hgb Group (g/dl)
(n)
Yes
(257)
No
(523)
P* <12
(191)
12-12.9
(158)
13-13.9
(156)
>14
(275)
P†
KCCQ 
Functional 
Status
55 ± 22 60 ± 22 0.006 54 ± 22 56 ± 22 58 ± 22 64 ± 21 <0.001
Symptoms 58 ± 24 63 ± 24 0.006 56 ± 24 59 ± 24 62 ± 23 66 ± 24 <0.001
Clinical 56 ± 21 59 ± 21 0.022 54 ± 21 56 ± 20 58 ± 22 62 ± 20 <0.001
MLHF
Physical 19 ± 11 18 ± 12 0.041 20 ± 11 19 ± 11 18 ± 12 16 ± 11 0.003
Emotional 10 ± 
7.7
9.3 ± 
7.7
0.222 10 ± 
7.8
10 ± 
8.0
9.7 ± 
8.0
8.8 ± 
7.3
0.227
Summary 44 ± 26 41 ± 26 0.154 45 ± 26 44 ± 26 43 ± 27 39 ± 26 0.061
*P value from t-test, †P value from ANOVA. Both analyses based on unadjusted QoL 
scores.
preTIC TIC
HEMODYNAMICS preDobutami
ne
Dobutami
ne
preDobutami
ne
Dobutami
ne
Heart Rate (min-1) 115±19 146±14* 125±14 171±38*
dP/dtmax (mmHg/s) 1,850±458 3,170±828
*
1,530±468† 2,420±506
*
LVPmax (mmHg) 110±11 129±15* 115±13 127±17*
LVEDP (mmHg) 17±8 18±11 38±7† 42±11
LVESP (mmHg) 88±12 95±10 93±14 100±19
LVEDV (mL) 178±17 163±13* 226±19† 224±21
LVESV (mL) 139±15 123±8 189±21† 185±28
